Privileged scaffolds in medicinal chemistry: Studies on pyrazolo[1,5-a]pyrimidines on sulfonamide containing Carbonic Anhydrase inhibitors.
Gumus, A., Bozdag, M., Angeli, A., Peat, T.S., Carta, F., Supuran, C.T., Selleri, S.(2021) Bioorg Med Chem Lett 49: 128309-128309
- PubMed: 34371130 
- DOI: https://doi.org/10.1016/j.bmcl.2021.128309
- Primary Citation of Related Structures:  
7MU3 - PubMed Abstract: 
We report for the first time a small series of compounds endowed in vitro with inhibitory properties for the human (h) expressed Carbonic Anhydrase (CAs, E.C. 4.2.1.1) enzymes of physiological interest (i.e. I, II, VA, IX and XII) and bearing the pyrazolo[1,5-a]pyrimidine (PP) scaffold at the tail section. Among the series reported, 1a-3a, 7a, 8a, 1b and 2b resulted effective ligands and with good selectivities for the hCAs II, IX or XII. In consideration of the nearly matching K I values of 7a for both the hCA II and IX (i.e. 26.4 and 23.0 nM respectively) we explored its binding mode within the CA IX mimic isoform by means of X-ray crystal experiments on the corresponding adduct.
Organizational Affiliation: 
Balıkesir University, Faculty of Science and Art, Department of Chemistry, 10145 Balıkesir, Turkey.